Education
About Us
Working with TipRanks
Follow Us
Japan Medical Dynamic Marketing, Inc. (JP:7600)
:7600
7600 Stock Chart & Stats
¥487.00
-¥2.00(-0.33%)
At close: 4:00 PM EST
¥487.00
-¥2.00(-0.33%)
Day’s Range― - ―
52-Week Range¥460.00 - ¥758.00
Previous CloseN/A
Volume41.50K
Average Volume (3M)89.74K
Market Cap
¥18.57B
Enterprise Value¥21.05B
Total Cash (Recent Filing)¥2.35B
Total Debt (Recent Filing)¥4.35B
Price to Earnings (P/E)14.8
Beta0.49
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.12%
Share Statistics
EPS (TTM)N/A
Shares Outstanding26,475,880
10 Day Avg. Volume96,020
30 Day Avg. Volume89,743
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)0.61
Price to Sales (P/S)0.60
P/FCF Ratio-29.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthLow leverage and a healthy equity base give the company financial flexibility to fund operations, absorb shocks, and pursue selective investments without heavy reliance on debt. This conservative capital structure supports operational continuity and strategic optionality over the next several months.
Stable Gross MarginsConsistently stable gross margins imply durable pricing power or manufacturing efficiency in the device business. That stability forms a reliable foundation for restoring operating profitability if operating expenses are controlled, aiding margin recovery over a medium-term horizon.
Operating Cash ConversionAn adequate operating cash flow to net income ratio indicates core operations convert earnings into cash reasonably well. Even with negative free cash flow in 2025, good cash conversion suggests management can improve liquidity through working-capital management or capex timing, supporting near-term durability.
Bears Say
Negative ProfitabilityA negative net profit margin in 2025 shows the company is losing money at the bottom line. Persistent losses erode retained earnings, constrain internal reinvestment, increase reliance on external funding, and limit the firm's ability to execute strategic initiatives over the medium term.
Negative Free Cash FlowNegative free cash flow reduces the company's internal capacity to finance R&D, capex, and working capital needs. Over several months this can force external financing or spending cuts, raising execution risk on growth projects and putting pressure on liquidity despite low leverage.
Declining Operating MarginsWorsening EBIT and EBITDA margins point to structural cost pressures or reduced operational efficiency. Continued margin erosion undermines sustainable profitability, shrinks the buffer to absorb shocks, and limits the company's ability to reinvest in product development and competitive positioning.
Japan Medical Dynamic Marketing, Inc. News
7600 FAQ
What was Japan Medical Dynamic Marketing, Inc.’s price range in the past 12 months?
Japan Medical Dynamic Marketing, Inc. lowest stock price was ¥460.00 and its highest was ¥758.00 in the past 12 months.
What is Japan Medical Dynamic Marketing, Inc.’s market cap?
Japan Medical Dynamic Marketing, Inc.’s market cap is ¥18.57B.
When is Japan Medical Dynamic Marketing, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Japan Medical Dynamic Marketing, Inc.’s earnings last quarter?
Currently, no data Available
Is Japan Medical Dynamic Marketing, Inc. overvalued?
According to Wall Street analysts Japan Medical Dynamic Marketing, Inc.’s price is currently Overvalued.
Does Japan Medical Dynamic Marketing, Inc. pay dividends?
Japan Medical Dynamic Marketing, Inc. pays a Annually dividend of ¥15 which represents an annual dividend yield of 3.12%. See more information on Japan Medical Dynamic Marketing, Inc. dividends here
What is Japan Medical Dynamic Marketing, Inc.’s EPS estimate?
Japan Medical Dynamic Marketing, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Japan Medical Dynamic Marketing, Inc. have?
Japan Medical Dynamic Marketing, Inc. has 26,475,880 shares outstanding.
What happened to Japan Medical Dynamic Marketing, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Japan Medical Dynamic Marketing, Inc.?
Currently, no hedge funds are holding shares in JP:7600
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Japan Medical Dynamic Marketing, Inc.
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury; spinal fixation devices for the use in spinal instability surgery; and artificial bone fillers for the treatment of bone fractures, tumors, and other defects. It offers its products to medical professionals and hospitals. The company was incorporated in 1973 and is headquartered in Tokyo, Japan.
Technical Analysis
3-D Matrix
―
Create Medic Co., Ltd.
―
Techno Medica Co., Ltd.
―
Colan Totte.Co.,Ltd.
―
Koken Ltd.
―
Options Prices
Currently, No data available
---